Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
Q3 LONG ANSWER 10M ★ High-yield

Classify lymphomas. Describe Hodgkin lymphoma and differentiate it from non-Hodgkin lymphoma.

Pathology · 2nd Professional — Para-Clinical

Definition and Classification

Lymphomas are malignant neoplasms of lymphoid tissue, arising in lymph nodes or extranodal lymphoid tissue, and divided into hodgkin and non-hodgkin lymphoma.

Hodgkin Lymphoma

  • Bimodal age distribution — a peak in young adults (15–35) and another after 50
  • Arises in a single node or chain and spreads contiguously to adjacent groups — which is what makes it curable by radiotherapy
  • The neoplastic cell is the REED–sternberg cell, which forms only a small minority of the tumour mass; the bulk is a reactive infiltrate of lymphocytes, eosinophils, plasma cells and histiocytes

The Reed–Sternberg cell

  • Large cell with a bilobed or bi-nucleate nucleus, each with a prominent eosinophilic nucleolus surrounded by a clear halo — the "owl-eye" appearance
  • Immunophenotype — CD15 and CD30 positive; CD45 and CD20 negative
  • Derived from a germinal centre B cell that has lost its B cell programme
  • Variants — lacunar cell (nodular sclerosis), popcorn or lymphohistiocytic cell (nodular lymphocyte predominant, which is CD20 positive and CD15/CD30 negative), and mummified cells
SubtypeFrequencyFeaturesPrognosis
Nodular sclerosisThe commonest, 65–70%Young women; mediastinal mass; broad collagen bands dividing the node into nodules; lacunar cellsGood
Mixed cellularity20–25%Older men; abundant classical Reed–Sternberg cells in a mixed inflammatory background; associated with EBV and HIVIntermediate
Lymphocyte rich5%Few Reed–Sternberg cellsVery good
Lymphocyte depletedUnder 5%Elderly, HIV; abundant Reed–Sternberg cells with few lymphocytesWorst
Nodular lymphocyte predominant5%Popcorn cells; CD20 positive; behaves like a B cell lymphomaGood, but late relapses

CLINICAL PEARL

The prognosis follows the lymphocyte count, not the Reed–Sternberg count. The more lymphocytes and the fewer neoplastic cells, the better the outcome — lymphocyte-rich does best and lymphocyte-depleted worst. The reactive infiltrate represents the host response, and its vigour predicts survival.

Non-hodgkin Lymphoma

  • Far more heterogeneous — over 60 entities in the WHO classification; about 85% are of B cell origin
  • Spreads non-contiguously and is often disseminated at presentation, with frequent marrow and extranodal involvement
  • Extranodal sites — stomach (malt), skin, brain, testis, thyroid, Waldeyer ring
TypeGeneticsFeatures
Diffuse large B cell lymphomaBcl-6, bcl-2, MYC rearrangementsThe commonest NHL; aggressive but curable with R-chop
Follicular lymphomaT(14;18) — bcl-2 overexpressionIndolent but incurable; cells accumulate because they do not die
Burkitt lymphomaT(8;14) — MYC"starry sky" appearance from tingible-body macrophages among sheets of blasts; the fastest growing human tumour; endemic African form affects the jaw and is EBV-associated; sporadic form affects the abdomen
Malt lymphomaT(11;18)Gastric; caused by helicobacter pylori and may regress on eradicating it
Mantle cell lymphomaT(11;14) — cyclin D1Aggressive, poor prognosis
Adult T cell leukaemia/lymphomaHTLV-1Skin lesions, hypercalcaemia, lytic bone lesions

Hodgkin Compared with Non-hodgkin

FeatureHodgkinNon-hodgkin
SpreadContiguous and orderlyNon-contiguous, unpredictable
Stage at presentationOften localisedUsually disseminated
Extranodal involvementUncommonCommon
Mesenteric nodes and Waldeyer ringRarelyCommonly
Marrow involvementUncommonCommon
B symptomsFrequentLess common
Diagnostic cellReed–Sternberg cell in a reactive backgroundSheets of neoplastic lymphoid cells
PrognosisGenerally better — over 80% cureVery variable

Staging and B Symptoms

Ann Arbor stageExtent
IOne lymph node region
IITwo or more regions on the same side of the diaphragm
IIIRegions on both sides of the diaphragm
IVDiffuse extranodal involvement — marrow, liver, lung
  • Suffix A — no systemic symptoms; suffix B — B symptoms present: unexplained fever above 38°C, drenching night sweats, and weight loss of more than 10% in six months
  • Suffix E — localised extranodal extension; S — splenic involvement
  • PEL–ebstein fever — a cyclical fever over one to two weeks alternating with afebrile periods; characteristic of Hodgkin lymphoma though uncommon
  • Alcohol-induced pain in involved nodes is rare but almost specific

Applied Aspects

  • Diagnosis requires an excision biopsy of a whole node — fine needle aspiration and core biopsy are inadequate, because the architecture is essential to classification
  • In India, tuberculous lymphadenitis is the chief differential of persistent lymphadenopathy, and must be excluded by staining and culture
  • Late effects of cure are now a major concern — second malignancies (breast cancer after mantle radiotherapy, AML after alkylating agents), cardiac disease, hypothyroidism and infertility
  • Fertility preservation must be discussed before treatment, since these are young patients with a high chance of cure
  • Pet-CT is used for staging and for assessing response, and an early interim pet now guides how much treatment is given
  • Rituximab (anti-CD20) transformed B cell NHL, and is the reason diffuse large B cell lymphoma is now curable in the majority

All questions in Haematology II: Leukaemias, Lymphomas & Haemostasis

  1. Q1Classify leukaemias. Describe the clinical features and laboratory diagnosis of acute leukaemia and differentiate AML from ALL. ★
  2. Q2Describe chronic myeloid leukaemia and chronic lymphocytic leukaemia with their clinical features and laboratory findings. ★
  3. Q3Classify lymphomas. Describe Hodgkin lymphoma and differentiate it from non-Hodgkin lymphoma. ★
  4. Q4Describe the clinical features, laboratory diagnosis and complications of multiple myeloma. ★
  5. Q5Describe the approach to a patient with a bleeding disorder. Interpret the coagulation screening tests and classify the causes of thrombocytopenia. ★
  6. SN1Describe immune thrombocytopenic purpura with its types, features and management. ★
  7. SN2Describe haemophilia with its genetics, clinical features and laboratory diagnosis. ★
  8. SN3Describe von Willebrand disease and differentiate it from haemophilia A. ★
  9. SN4Describe the Reed-Sternberg cell with its variants and immunophenotype. ★
  10. SN5Define leukaemoid reaction. Differentiate it from chronic myeloid leukaemia and add a note on the leucoerythroblastic reaction. ★
  11. SN6Describe the indications, sites and interpretation of bone marrow examination. ★
  12. SN7Describe the hazards of blood transfusion.

Every Pathology chapter →

Scroll to Top